WASHINGTON (AP) — A clinical trial evaluating a vaccine designed to protect against the new coronavirus will begin Monday. A government official says the first participant in the trial will receive the experimental vaccine that day. The National Institutes of Health is funding the trial that is taking place at a Kaiser Permanente research facility in Seattle. Testing will begin with 45 young, healthy volunteers with different doses of shots co-developed by NIH and Moderna Inc. Public health officials say it will take a year to 18 months to fully validate any potential vaccine.
© 2024 Nebraska Rural Radio Association. All rights reserved. Republishing, rebroadcasting, rewriting, redistributing prohibited. Copyright Information
